Having diagnosed your patient, the next step is to classify and document the severity of your patient’s airflow obstruction.  This will help guide your treatment decisions.

Grades and severity of airway obstruction - GOLD

GOLD (2026) and NICE guidelines categorize airway obstruction seen in spirometry into levels which range from mild to very severe, based on the percentage of predicted FEV1. 

GOLD Grades and Severity of Airflow Obstruction in COPD

(based on post-bronchodilator FEV1)

GOLD 1: Mild FEV1 ≥ 80% predicted
GOLD 2: Moderate 50% ≤ FEV1 < 80% predicted
GOLD 3: Severe 30% ≤ FEV1 < 50% predicted
GOLD 4: Very severe FEV1 < 30% predicted

© 2023, 2024, Global Initiative for Chronic Obstructive Lung Disease, available from www.goldcopd.org, published in Deer Park, IL, USA.

Grades and severity of airway obstruction - ARTP

The Association for Respiratory Technology and Physiology (ARTP) recommends different, more updated way of classifying airway obstruction, which is used within their competency assessments. 

This approach uses Z-scores and describes airflow obstruction across five levels.

Using Z-scores helps avoids the bias that can occur when using percentage predicted values, particularly in very young or older people

Severity classification and probability of a result being found within a 
normal healthy population for various z-score thresholds
Threshold for Z-score Severity grading Approximate chance of finding this 
result in a healthy population
< - 1.645 Mild 1 in 20
< - 2.00 Moderate 1 in 40
< - 2.50 Moderately Severe 1 in 150
< - 3.00 Severe 1 in 750
< - 3.50 Very Severe 1 in 30,000

Whichever scale you use, remember: the severity of airflow obstruction does not always correlate to the impact the COPD is having on the patient and their life.

There is a lot of evidence to suggest that the severity of obstruction is not necessarily reflected in the patient’s symptoms. For example, a patient with grade 3 (severe) obstruction may be less affected by their symptoms than a person at grade 1 (mild).

This is because COPD is a heterogenous disease which means that every patient experiences symptoms, such as breathlessness differently.  

GOLD recommends using a holistic approach to understand the impact that your patient’s symptoms are having on their everyday life and what their risk of exacerbations is likely to be . 
Find out how to do this here.

Did you find this information useful?

We use your comments to improve our information. We cannot reply to comments left on this form. If you have health concerns or need clinical advice, call our helpline on 0300 222 5800 between 9am and 5pm on a weekday or email them.

Page last reviewed:
Next review due: